Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Kidney Diseases (Basel, Switzerland)
|
August 19, 2016
Autophagy in Chronic Kidney Diseases
Na Liu, Yingfeng Shi, Shougang Zhuang
Oncotarget
|
December 17, 2017
Recent advances on uric acid transporters
Liuqing Xu, Yingfeng Shi, Shougang Zhuang, et al.
Journal of Diabetes Research
|
May 18, 2017
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu, Liuqing Xu, Yingfeng Shi, et al.
Cytotechnology
|
August 1, 2025
CXCL1 promotes diabetic foot ulcer through activation of the TNF-α signaling pathway
Jinyun Lu, Yingfeng Shi, Zhuoqun Lin, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
April 7, 2021
Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis
Yingfeng Shi, Yan Hu, Binbin Cui, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
July 15, 2020
Peritoneal fibrosis and epigenetic modulation
Yi Wang, Yingfeng Shi, Min Tao, et al.
Frontiers in Pharmacology
|
May 13, 2022
The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
Xun Zhou, Hui Chen, Jinqing Li, et al.
Frontiers in Pharmacology
|
July 5, 2021
The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
Xun Zhou, Hui Chen, Yingfeng Shi, et al.
Clinical Science (London, England : 1979)
|
October 9, 2018
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
Jinfang Bao, Yingfeng Shi, Min Tao, et al.
Oncotarget
|
April 27, 2017
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats
Na Liu, Liuqing Xu, Yingfeng Shi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Kidney Diseases (Basel, Switzerland)
|
August 19, 2016
Autophagy in Chronic Kidney Diseases
Na Liu, Yingfeng Shi, Shougang Zhuang
Oncotarget
|
December 17, 2017
Recent advances on uric acid transporters
Liuqing Xu, Yingfeng Shi, Shougang Zhuang, et al.
Journal of Diabetes Research
|
May 18, 2017
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu, Liuqing Xu, Yingfeng Shi, et al.
Cytotechnology
|
August 1, 2025
CXCL1 promotes diabetic foot ulcer through activation of the TNF-α signaling pathway
Jinyun Lu, Yingfeng Shi, Zhuoqun Lin, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
April 7, 2021
Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis
Yingfeng Shi, Yan Hu, Binbin Cui, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
July 15, 2020
Peritoneal fibrosis and epigenetic modulation
Yi Wang, Yingfeng Shi, Min Tao, et al.
Frontiers in Pharmacology
|
May 13, 2022
The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
Xun Zhou, Hui Chen, Jinqing Li, et al.
Frontiers in Pharmacology
|
July 5, 2021
The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
Xun Zhou, Hui Chen, Yingfeng Shi, et al.
Clinical Science (London, England : 1979)
|
October 9, 2018
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
Jinfang Bao, Yingfeng Shi, Min Tao, et al.
Oncotarget
|
April 27, 2017
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats
Na Liu, Liuqing Xu, Yingfeng Shi, et al.
Page
of 6